 | • レポートコード：MRC2Q12-18943 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、シドホビルのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 シドホビルのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 シドホビルの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 シドホビルのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのシドホビルの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のシドホビルの売上および2028年までの予測に焦点を当てています。 シドホビルのグローバル主要企業には、Emcure Pharma、Mylan、Gilead Sciences、Tillomed Pharma、Marcan Pharmaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 シドホビル市場は、タイプとアプリケーションによって区分されます。世界のシドホビル市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 溶液、粉末 【アプリケーション別セグメント】 サイトメガロウイルス網膜炎治療、イボ局所治療、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - シドホビル製品概要 - タイプ別市場（溶液、粉末） - アプリケーション別市場（サイトメガロウイルス網膜炎治療、イボ局所治療、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のシドホビル販売量予測2017-2028 - 世界のシドホビル売上予測2017-2028 - シドホビルの地域別販売量 - シドホビルの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別シドホビル販売量 - 主要メーカー別シドホビル売上 - 主要メーカー別シドホビル価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（溶液、粉末） - シドホビルのタイプ別販売量 - シドホビルのタイプ別売上 - シドホビルのタイプ別価格 ・アプリケーション別市場規模（サイトメガロウイルス網膜炎治療、イボ局所治療、その他） - シドホビルのアプリケーション別販売量 - シドホビルのアプリケーション別売上 - シドホビルのアプリケーション別価格 ・北米市場 - 北米のシドホビル市場規模（タイプ別、アプリケーション別） - 主要国別のシドホビル市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのシドホビル市場規模（タイプ別、アプリケーション別） - 主要国別のシドホビル市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のシドホビル市場規模（タイプ別、アプリケーション別） - 主要国別のシドホビル市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のシドホビル市場規模（タイプ別、アプリケーション別） - 主要国別のシドホビル市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのシドホビル市場規模（タイプ別、アプリケーション別） - 主要国別のシドホビル市場規模（トルコ、サウジアラビア） ・企業情報 Emcure Pharma、Mylan、Gilead Sciences、Tillomed Pharma、Marcan Pharma ・産業チェーン及び販売チャネル分析 - シドホビルの産業チェーン分析 - シドホビルの原材料 - シドホビルの生産プロセス - シドホビルの販売及びマーケティング - シドホビルの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - シドホビルの産業動向 - シドホビルのマーケットドライバー - シドホビルの課題 - シドホビルの阻害要因 ・主な調査結果 |
It is a topical or injectable antiviral medication primarily used as a treatment for cytomegalovirus (CMV) retinitis (an infection of the retina of the eye) in people with AIDS.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Cidofovir is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Cidofovir is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Cidofovir is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Cidofovir include Emcure Pharma, Mylan, Gilead Sciences, Tillomed Pharma and Marcan Pharma, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Cidofovir manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Cidofovir market. Further, it explains the major drivers and regional dynamics of the global Cidofovir market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Emcure Pharma
Mylan
Gilead Sciences
Tillomed Pharma
Marcan Pharma
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by dosage form and by application segments based on sales, price, and value for the period 2017-2028.
Cidofovir Segment by Dosage Form
Solution
Sowder
Cidofovir Segment by Application
Treatment of Cytomegalovirus Retinitis
Local Treatment of Warts
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Cidofovir market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Cidofovir, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Cidofovir, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Cidofovir, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cidofovir sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Cidofovir market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Cidofovir sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Emcure Pharma, Mylan, Gilead Sciences, Tillomed Pharma and Marcan Pharma, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Cidofovir in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Cidofovir manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by dosage form, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by dosage form, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by dosage form, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by dosage form, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by dosage form, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cidofovir sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Cidofovir Product Introduction
1.2 Market by Dosage Form
1.2.1 Global Cidofovir Market Size Growth Rate by Dosage Form, 2017 VS 2021 VS 2028
1.2.2 Solution
1.2.3 Sowder
1.3 Market by Application
1.3.1 Global Cidofovir Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Treatment of Cytomegalovirus Retinitis
1.3.3 Local Treatment of Warts
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cidofovir Sales Estimates and Forecasts 2017-2028
2.2 Global Cidofovir Revenue Estimates and Forecasts 2017-2028
2.3 Global Cidofovir Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Cidofovir Sales by Region
2.4.1 Global Cidofovir Sales by Region (2017-2022)
2.4.2 Global Sales Cidofovir by Region (2023-2028)
2.5 Global Cidofovir Revenue by Region
2.5.1 Global Cidofovir Revenue by Region (2017-2022)
2.5.2 Global Cidofovir Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Cidofovir Sales by Manufacturers
3.1.1 Global Top Cidofovir Manufacturers by Sales (2017-2022)
3.1.2 Global Cidofovir Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cidofovir in 2021
3.2 Global Cidofovir Revenue by Manufacturers
3.2.1 Global Cidofovir Revenue by Manufacturers (2017-2022)
3.2.2 Global Cidofovir Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Cidofovir Revenue in 2021
3.3 Global Cidofovir Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Cidofovir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Cidofovir Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Dosage Form
4.1 Global Cidofovir Sales by Dosage Form
4.1.1 Global Cidofovir Historical Sales by Dosage Form (2017-2022)
4.1.2 Global Cidofovir Forecasted Sales by Dosage Form (2023-2028)
4.1.3 Global Cidofovir Sales Market Share by Dosage Form (2017-2028)
4.2 Global Cidofovir Revenue by Dosage Form
4.2.1 Global Cidofovir Historical Revenue by Dosage Form (2017-2022)
4.2.2 Global Cidofovir Forecasted Revenue by Dosage Form (2023-2028)
4.2.3 Global Cidofovir Revenue Market Share by Dosage Form (2017-2028)
4.3 Global Cidofovir Price by Dosage Form
4.3.1 Global Cidofovir Price by Dosage Form (2017-2022)
4.3.2 Global Cidofovir Price Forecast by Dosage Form (2023-2028)
5 Market Size by Application
5.1 Global Cidofovir Sales by Application
5.1.1 Global Cidofovir Historical Sales by Application (2017-2022)
5.1.2 Global Cidofovir Forecasted Sales by Application (2023-2028)
5.1.3 Global Cidofovir Sales Market Share by Application (2017-2028)
5.2 Global Cidofovir Revenue by Application
5.2.1 Global Cidofovir Historical Revenue by Application (2017-2022)
5.2.2 Global Cidofovir Forecasted Revenue by Application (2023-2028)
5.2.3 Global Cidofovir Revenue Market Share by Application (2017-2028)
5.3 Global Cidofovir Price by Application
5.3.1 Global Cidofovir Price by Application (2017-2022)
5.3.2 Global Cidofovir Price Forecast by Application (2023-2028)
6 North America
6.1 North America Cidofovir Market Size by Dosage Form
6.1.1 North America Cidofovir Sales by Dosage Form (2017-2028)
6.1.2 North America Cidofovir Revenue by Dosage Form (2017-2028)
6.2 North America Cidofovir Market Size by Application
6.2.1 North America Cidofovir Sales by Application (2017-2028)
6.2.2 North America Cidofovir Revenue by Application (2017-2028)
6.3 North America Cidofovir Market Size by Country
6.3.1 North America Cidofovir Sales by Country (2017-2028)
6.3.2 North America Cidofovir Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Cidofovir Market Size by Dosage Form
7.1.1 Europe Cidofovir Sales by Dosage Form (2017-2028)
7.1.2 Europe Cidofovir Revenue by Dosage Form (2017-2028)
7.2 Europe Cidofovir Market Size by Application
7.2.1 Europe Cidofovir Sales by Application (2017-2028)
7.2.2 Europe Cidofovir Revenue by Application (2017-2028)
7.3 Europe Cidofovir Market Size by Country
7.3.1 Europe Cidofovir Sales by Country (2017-2028)
7.3.2 Europe Cidofovir Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Cidofovir Market Size by Dosage Form
8.1.1 Asia Pacific Cidofovir Sales by Dosage Form (2017-2028)
8.1.2 Asia Pacific Cidofovir Revenue by Dosage Form (2017-2028)
8.2 Asia Pacific Cidofovir Market Size by Application
8.2.1 Asia Pacific Cidofovir Sales by Application (2017-2028)
8.2.2 Asia Pacific Cidofovir Revenue by Application (2017-2028)
8.3 Asia Pacific Cidofovir Market Size by Region
8.3.1 Asia Pacific Cidofovir Sales by Region (2017-2028)
8.3.2 Asia Pacific Cidofovir Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Cidofovir Market Size by Dosage Form
9.1.1 Latin America Cidofovir Sales by Dosage Form (2017-2028)
9.1.2 Latin America Cidofovir Revenue by Dosage Form (2017-2028)
9.2 Latin America Cidofovir Market Size by Application
9.2.1 Latin America Cidofovir Sales by Application (2017-2028)
9.2.2 Latin America Cidofovir Revenue by Application (2017-2028)
9.3 Latin America Cidofovir Market Size by Country
9.3.1 Latin America Cidofovir Sales by Country (2017-2028)
9.3.2 Latin America Cidofovir Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Cidofovir Market Size by Dosage Form
10.1.1 Middle East and Africa Cidofovir Sales by Dosage Form (2017-2028)
10.1.2 Middle East and Africa Cidofovir Revenue by Dosage Form (2017-2028)
10.2 Middle East and Africa Cidofovir Market Size by Application
10.2.1 Middle East and Africa Cidofovir Sales by Application (2017-2028)
10.2.2 Middle East and Africa Cidofovir Revenue by Application (2017-2028)
10.3 Middle East and Africa Cidofovir Market Size by Country
10.3.1 Middle East and Africa Cidofovir Sales by Country (2017-2028)
10.3.2 Middle East and Africa Cidofovir Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Emcure Pharma
11.1.1 Emcure Pharma Corporation Information
11.1.2 Emcure Pharma Overview
11.1.3 Emcure Pharma Cidofovir Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Emcure Pharma Cidofovir Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Emcure Pharma Recent Developments
11.2 Mylan
11.2.1 Mylan Corporation Information
11.2.2 Mylan Overview
11.2.3 Mylan Cidofovir Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Mylan Cidofovir Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Mylan Recent Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Corporation Information
11.3.2 Gilead Sciences Overview
11.3.3 Gilead Sciences Cidofovir Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Gilead Sciences Cidofovir Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Gilead Sciences Recent Developments
11.4 Tillomed Pharma
11.4.1 Tillomed Pharma Corporation Information
11.4.2 Tillomed Pharma Overview
11.4.3 Tillomed Pharma Cidofovir Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Tillomed Pharma Cidofovir Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Tillomed Pharma Recent Developments
11.5 Marcan Pharma
11.5.1 Marcan Pharma Corporation Information
11.5.2 Marcan Pharma Overview
11.5.3 Marcan Pharma Cidofovir Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Marcan Pharma Cidofovir Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Marcan Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cidofovir Industry Chain Analysis
12.2 Cidofovir Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cidofovir Production Mode & Process
12.4 Cidofovir Sales and Marketing
12.4.1 Cidofovir Sales Channels
12.4.2 Cidofovir Distributors
12.5 Cidofovir Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Cidofovir Industry Trends
13.2 Cidofovir Market Drivers
13.3 Cidofovir Market Challenges
13.4 Cidofovir Market Restraints
14 Key Findings in The Global Cidofovir Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer